Overview

MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9)

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The present study is designed to assess the safety and tolerability of escalating, multiple ascending doses of Cavosonstat (N91115) in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Nivalis Therapeutics, Inc.